As Roswell Park Comprehensive Cancer Center continues to utilize the latest immunotherapies that spell hope for so many of our patients, BlueCross BlueShield of Western New York has recognized us as a Blue Distinction Center for Cellular Immunotherapy — CAR-T (chimeric antigen receptor). The center is one of two to receive this distinction in New York State.
Little is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors. But a study out of…
Roswell Park has launched the first clinical trial in the United States to study the CIMAvax-EGF® vaccine, a lung cancer treatment that was developed in…
“I was given a choice to see a doctor at another facility, but because of what I know about my wife’s work and the cutting-…
One of the most influential and accomplished figures in the field of cancer immunotherapy has returned to his Western New York roots to take on…
When financial concerns weigh heavily on an individual who is in treatment for cancer, they can affect the outcome of that treatment. New research from…
A toddler from Niagara Falls, NY, will celebrate her 2nd birthday this month after successfully undergoing CAR T immunotherapy and stem cell transplant through the…
Join experts from around the world for a live fireside chat to learn about Indigenous cancer care and COVID-19. Experts will discuss both western perspectives…
Only when her doctors told her she was going to die without one did Rachel understand how critical a bone marrow transplant was. Just two…
This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered…
Cancer-related fatigue is a deeper, longer-lasting type of fatigue that is not usually relieved by sleep and rest. It can interfere with your ability to…
